Company profile · Biotech & medical
Savior Lifetec
松瑞製藥股份有限公司 · 4167
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Savior Lifetec develops and manufactures high-quality sterile active pharmaceutical ingredients and formulations, specializing in carbapenem antibiotics.[1]
The company provides vertical production integration from active pharmaceutical ingredients to finished dosage forms, utilizing sterile processing technology.[1]
Its products and facilities comply with international GMP standards and have passed inspections by government health authorities including the US FDA and European agencies.[2]
Savior Lifetec is headquartered in the Southern Taiwan Science Park in Tainan City.[3]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$136m | +21.3% | +30.8% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$3m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Savior Lifetec Corporation |
|---|---|
| Chinese name | 松瑞製藥股份有限公司 |
| Stock code | 4167 (TPEx) |
| Industry | Biotech & medical |
| Founded | 30 Jan 2004 |
| Listed | 08 Sep 2015 |
| Paid-in capital | NT$3.3bn |
| Chairman | 漢友財務管理顧問股份有限公司代表人李香雲 |
| President | 陳志芳 |
| Headquarters | No.1,Nanke 6th Road,Xinshi Dist,Southern Taiwan Science Park, Tainan City,Taiwan 744094,R.O.C. |
| Website | https://www.saviorlifetec.com.tw/ |
| Official business description | 西藥製造業(原料藥產品及註冊針劑) · 原料藥之中間體物 · 生物製藥技術服務 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- 松瑞製藥股份有限公司 · website · retrieved 04 Nov 2026
- 松瑞製藥股份有限公司 · website · retrieved 04 Nov 2026
- MOPS 公司基本資料 松瑞製藥股份有限公司 · mops · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list